Antidote Technologies focuses on enhancing clinical trial recruitment through innovative solutions that address the significant challenge of participant shortages in medical research. The company employs a precision recruitment strategy designed to expedite the process of filling clinical trials for sponsors. This is complemented by their smart Match search engine, which simplifies the experience for patients seeking suitable clinical trials based on their specific conditions. By streamlining the connection between patients and research opportunities, Antidote aims to reduce the delays that often hinder medical research, ultimately benefiting both patients and researchers.

In addition to their recruitment services, Antidote recognizes the critical role of caregivers in the clinical trial process. Caregivers not only assist patients in navigating the complexities of participation but also serve as vital decision-makers regarding treatment options. Antidote emphasizes the importance of engaging caregivers in recruitment campaigns, acknowledging their influence and the support they provide throughout the trial journey. By addressing the challenges faced by caregivers and offering tailored resources, Antidote seeks to create a more inclusive and effective clinical trial environment that enhances outcomes for both patients and their caregivers.

United States

Antidote is on a mission to catalyze medical innovation by successfully connecting patients and researchers as the best-in-class recruiter for clinical studies.

Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in New York, NY and London, U.K. For more information, visit http://www.antidote.me.

Antidote Technologies

Company Details